Merck announced on Feb. 2, 2015 the repatriation of all responsibility for its diabetes and thyroid brands in Russia. As of Jan. 1, 2015, all activities for the brands moved from Takeda Pharmaceutical Company, Merck s marketing partner, back to Merck in Russia. The shift to the home orOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.